Ge Li melds WuXi VC with Front­line, cre­at­ing an $800M trans-Pa­cif­ic pow­er­house fund now hunt­ing fresh biotech cap­i­tal

WuXi’s Ge Li is lever­ag­ing up a whole new biotech ven­ture group with am­bi­tious plans to add to the hun­dreds of mil­lions of dol­lars it’s in­vest­ed in glob­al biotechs.

Ge Li is throw­ing in his port­fo­lio of 40 biotechs at WuXi Health­care Ven­tures with Front­line BioVen­tures’ 20 in­vest­ments, ac­count­ing for some $800 mil­lion of man­aged as­sets. Their new group is be­ing re­named 6 Di­men­sions Cap­i­tal and Front­line chief Leon Chen — a vet­er­an Fi­deli­ty hand — will take over as CEO with Ge Li stand­ing in as chair­man.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.